Author: Himanshu Patni
10 March 2023
The global antacids market is expected to register a CAGR of around 9% over the period of 2022-2028. This is mainly due to the rising rate of an aging population with the adoption of acid reflux, gastric ulcers, heartburn, and ingestion problem. Also, stringent government regulations coupled with the growing focus of major stakeholders in the healthcare system to adopt to make antacid products more sustainable with fewer side effects and eco-friendlier is also contributing to the market growth. Further, major healthcare companies are investing heavily in their products due to rising gastrointestinal health issues cases, an increase in the demand for the e-commerce distribution channel, and awareness of healthcare expenditure is acting as a growth catalyst to the industry. For instance, according to the National Center for Health Statistics, in 2018, globally more than 14.8 million adults were with diagnosed ulcers. The considerably large number of people suffering from gastric ulcers, heartburn, and ingestion problem increases the demand for the antacids market. As a result, the government is focusing on raising awareness about the illnesses and the effect which significantly contributes to the market for antacids. Therefore, the market for antacids is expected to witness significant growth during the forecast period.
For a detailed analysis of the Global Antacids Market browse through – https://univdatos.com/report/antacids-market/
Based on drug class, the market is classified into proton pump inhibitors, H2 antagonists, acid neutralizers, and others. The proton pump inhibitors category accounted for a significant share of the market. This is mainly due to its use in the treatment of patients suffering from chronic acidity. The advanced proton pump inhibitors drugs, esomeprazole, and rabeprazole are more reliable and effective. These are known to have a greater and long-lasting effect during the evening after 5 days of administration. As per drugwatch, about 15 million people in the U.S. use PPIs every year.
Based on distribution channels, the market is categorized into hospital pharmacies, retail pharmacies, online pharmacies, and others. Among these, online pharmacies are expected to witness the highest CAGR during the forecast period. Online pharmacies are widely used for easy access to antacids because antacids generally do not require a prescription, in other words, they are self-prescribed. Furthermore, antacids are the most common over-the-counter products purchased in the United States. The high growth of this segment will drive the market growth.
Request for Sample of the report browse through – https://univdatos.com/get-a-free-sample-form-php/?product_id=25765
For a better understanding of the market adoption of the antacid. The market is analyzed based on its worldwide presence in the countries such as North America (US, Canada, Rest of North America); Europe (Germany, UK, France, Italy, Spain, and Rest of Europe); Asia-Pacific (China, Japan, India, Australia, Rest of Asia-Pacific), and Rest of World. North America is expected to witness the highest CAGR during the forecast period on account of the growing various antacids and medical treatment activities in countries like the U.S. and Canada. Furthermore, according to the Canadian Digestive Health Foundation, it is estimated that the prevalence of GERD is 15% in North America. Thus, providing care to people suffering from gastroesophageal reflux diseases such as the provision of essential antacid medicines and increasing awareness of over-the-counter antacids for self-medication then the industry owing to the presence of well-established market players and frequent product launches in the region. Furthermore, many medical and antacid companies are headquartered in the region and are now focusing on coming up with novel drugs in the antacid market.
Some of the major players operating in the market include GlaxoSmithKline plc., Pfizer Inc., Bayer AG, Dr. Reddy’s Laboratories Ltd., AstraZeneca PLC., Boehringer Ingelheim GmbH, Sun Pharmaceuticals Industries Ltd., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Johnson & Johnson
Global Antacids Market Segmentation
Market Insight, by Drug Class
· Proton pump inhibitors
· H2 antagonist
· Acid neutralizers
· Others (Pro-Motility Agents)
Market Insight, by Application
· Tablets
· Capsules
· Suspension
· Drops
· Others
Market Insight, by Distribution Channel
· Hospital Pharmacies
· Retail Pharmacies
· Online Pharmacies
· Others
Market Insight, by Region
· North America
o U.S.
o Canada
o Rest of North America
· Europe
o Germany
o UK
o France
o Italy
o Spain
o Rest of Europe
· Asia-Pacific
o China
o Japan
o India
o Australia
o Rest of Asia-Pacific
· Rest of World
Top Company Profiles
• GlaxoSmithKline plc.
• Pfizer Inc.
• Bayer AG
• Dr. Reddy’s Laboratories Ltd.
• AstraZeneca PLC.
• Boehringer Ingelheim GmbH
• Sun Pharmaceuticals Industries Ltd.
• Takeda Pharmaceutical Company Limited
• Abbott Laboratories
• Johnson & Johnson
Get a call back
